nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4A—autistic disorder	0.425	0.547	CbGaD
Flavoxate—PDE4B—autistic disorder	0.353	0.454	CbGaD
Flavoxate—PDE4C—mouth—autistic disorder	0.00439	0.055	CbGeAlD
Flavoxate—PDE8B—forebrain—autistic disorder	0.00299	0.0375	CbGeAlD
Flavoxate—PDE4C—brainstem—autistic disorder	0.00287	0.0359	CbGeAlD
Flavoxate—PDE4C—forebrain—autistic disorder	0.00277	0.0347	CbGeAlD
Flavoxate—PDE8B—telencephalon—autistic disorder	0.00275	0.0345	CbGeAlD
Flavoxate—PDE8A—eye—autistic disorder	0.00271	0.034	CbGeAlD
Flavoxate—PDE4C—telencephalon—autistic disorder	0.00255	0.0319	CbGeAlD
Flavoxate—PDE8A—telencephalon—autistic disorder	0.00247	0.031	CbGeAlD
Flavoxate—PDE7A—head—autistic disorder	0.00246	0.0308	CbGeAlD
Flavoxate—PDE7A—nervous system—autistic disorder	0.00233	0.0292	CbGeAlD
Flavoxate—PDE7A—central nervous system—autistic disorder	0.00225	0.0281	CbGeAlD
Flavoxate—PDE4D—telencephalon—autistic disorder	0.00224	0.0281	CbGeAlD
Flavoxate—PDE7B—head—autistic disorder	0.00215	0.0269	CbGeAlD
Flavoxate—PDE7B—nervous system—autistic disorder	0.00204	0.0255	CbGeAlD
Flavoxate—PDE4A—telencephalon—autistic disorder	0.00198	0.0249	CbGeAlD
Flavoxate—PDE7B—central nervous system—autistic disorder	0.00196	0.0246	CbGeAlD
Flavoxate—PDE7A—brain—autistic disorder	0.00178	0.0223	CbGeAlD
Flavoxate—PDE8B—head—autistic disorder	0.00171	0.0215	CbGeAlD
Flavoxate—PDE8B—nervous system—autistic disorder	0.00162	0.0203	CbGeAlD
Flavoxate—PDE4C—head—autistic disorder	0.00159	0.0199	CbGeAlD
Flavoxate—PDE8B—central nervous system—autistic disorder	0.00156	0.0196	CbGeAlD
Flavoxate—PDE7B—brain—autistic disorder	0.00156	0.0195	CbGeAlD
Flavoxate—PDE8B—cerebellum—autistic disorder	0.00153	0.0191	CbGeAlD
Flavoxate—PDE4C—nervous system—autistic disorder	0.0015	0.0188	CbGeAlD
Flavoxate—PDE4C—central nervous system—autistic disorder	0.00145	0.0181	CbGeAlD
Flavoxate—PDE8A—cerebellum—autistic disorder	0.00137	0.0172	CbGeAlD
Flavoxate—PDE4B—forebrain—autistic disorder	0.00129	0.0161	CbGeAlD
Flavoxate—CHRM2—forebrain—autistic disorder	0.00128	0.016	CbGeAlD
Flavoxate—PDE4D—cerebellum—autistic disorder	0.00125	0.0156	CbGeAlD
Flavoxate—PDE8B—brain—autistic disorder	0.00124	0.0155	CbGeAlD
Flavoxate—PDE4B—telencephalon—autistic disorder	0.00118	0.0148	CbGeAlD
Flavoxate—CHRM2—telencephalon—autistic disorder	0.00117	0.0147	CbGeAlD
Flavoxate—CHRM1—forebrain—autistic disorder	0.00116	0.0146	CbGeAlD
Flavoxate—PDE4C—brain—autistic disorder	0.00115	0.0144	CbGeAlD
Flavoxate—PDE8A—brain—autistic disorder	0.00112	0.014	CbGeAlD
Flavoxate—PDE4A—cerebellum—autistic disorder	0.0011	0.0138	CbGeAlD
Flavoxate—CHRM1—telencephalon—autistic disorder	0.00107	0.0134	CbGeAlD
Flavoxate—PDE4D—brain—autistic disorder	0.00101	0.0127	CbGeAlD
Flavoxate—Raloxifene—CYP19A1—autistic disorder	0.000984	0.574	CrCbGaD
Flavoxate—PDE4A—brain—autistic disorder	0.000895	0.0112	CbGeAlD
Flavoxate—PDE4B—head—autistic disorder	0.000736	0.00923	CbGeAlD
Flavoxate—CHRM2—head—autistic disorder	0.000731	0.00916	CbGeAlD
Flavoxate—Antrafenine—PTGS2—autistic disorder	0.000729	0.426	CrCbGaD
Flavoxate—PDE4B—nervous system—autistic disorder	0.000698	0.00875	CbGeAlD
Flavoxate—CHRM2—nervous system—autistic disorder	0.000693	0.00869	CbGeAlD
Flavoxate—PDE4B—central nervous system—autistic disorder	0.000672	0.00842	CbGeAlD
Flavoxate—CHRM2—central nervous system—autistic disorder	0.000668	0.00837	CbGeAlD
Flavoxate—CHRM1—head—autistic disorder	0.000666	0.00834	CbGeAlD
Flavoxate—PDE4B—cerebellum—autistic disorder	0.000657	0.00823	CbGeAlD
Flavoxate—CHRM1—nervous system—autistic disorder	0.000631	0.00791	CbGeAlD
Flavoxate—CHRM1—central nervous system—autistic disorder	0.000608	0.00761	CbGeAlD
Flavoxate—PDE4B—brain—autistic disorder	0.000534	0.00669	CbGeAlD
Flavoxate—CHRM2—brain—autistic disorder	0.00053	0.00664	CbGeAlD
Flavoxate—CHRM1—brain—autistic disorder	0.000482	0.00605	CbGeAlD
Flavoxate—PDE4A—Signaling Pathways—PLA2G4A—autistic disorder	1.74e-05	0.000124	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ITGB3—autistic disorder	1.73e-05	0.000123	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—LEP—autistic disorder	1.73e-05	0.000123	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APOE—autistic disorder	1.73e-05	0.000123	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CALCA—autistic disorder	1.72e-05	0.000122	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AVP—autistic disorder	1.71e-05	0.000122	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRLR—autistic disorder	1.7e-05	0.000121	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF2—autistic disorder	1.7e-05	0.000121	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PTEN—autistic disorder	1.7e-05	0.000121	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—IL2—autistic disorder	1.69e-05	0.000121	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MEF2C—autistic disorder	1.69e-05	0.000121	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD1—autistic disorder	1.69e-05	0.00012	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL2—autistic disorder	1.68e-05	0.00012	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRLR—autistic disorder	1.68e-05	0.00012	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL6—autistic disorder	1.67e-05	0.000119	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD1—autistic disorder	1.67e-05	0.000119	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ITGB3—autistic disorder	1.65e-05	0.000117	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GRM8—autistic disorder	1.64e-05	0.000117	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD3—autistic disorder	1.63e-05	0.000116	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PRKCB—autistic disorder	1.63e-05	0.000116	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GRM8—autistic disorder	1.62e-05	0.000116	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR2A—autistic disorder	1.62e-05	0.000115	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL2—autistic disorder	1.62e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	1.62e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD3—autistic disorder	1.61e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—autistic disorder	1.61e-05	0.000115	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PLA2G4A—autistic disorder	1.61e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL5—autistic disorder	1.6e-05	0.000114	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—WNT2—autistic disorder	1.59e-05	0.000114	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—autistic disorder	1.59e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL6—autistic disorder	1.58e-05	0.000113	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PTEN—autistic disorder	1.58e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CALCA—autistic disorder	1.58e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL5—autistic disorder	1.58e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—WNT2—autistic disorder	1.57e-05	0.000112	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GHR—autistic disorder	1.57e-05	0.000112	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—IL2—autistic disorder	1.57e-05	0.000112	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MEF2C—autistic disorder	1.56e-05	0.000112	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CALCA—autistic disorder	1.56e-05	0.000111	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APC—autistic disorder	1.56e-05	0.000111	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CG—autistic disorder	1.56e-05	0.000111	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MAPK1—autistic disorder	1.55e-05	0.000111	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MAPK1—autistic disorder	1.55e-05	0.000111	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GHR—autistic disorder	1.55e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE4A—autistic disorder	1.55e-05	0.00011	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGF—autistic disorder	1.54e-05	0.00011	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR2A—autistic disorder	1.54e-05	0.00011	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL2—autistic disorder	1.54e-05	0.00011	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TSC2—autistic disorder	1.54e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE4A—autistic disorder	1.53e-05	0.000109	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ITGB3—autistic disorder	1.52e-05	0.000109	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APOE—autistic disorder	1.5e-05	0.000107	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—LEP—autistic disorder	1.5e-05	0.000107	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—autistic disorder	1.48e-05	0.000106	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TSC2—autistic disorder	1.46e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADRB2—autistic disorder	1.46e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AVPR1A—autistic disorder	1.45e-05	0.000103	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADRB2—autistic disorder	1.44e-05	0.000103	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—LEP—autistic disorder	1.43e-05	0.000102	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APOE—autistic disorder	1.43e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AVPR1A—autistic disorder	1.43e-05	0.000102	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF1—autistic disorder	1.43e-05	0.000102	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR2A—autistic disorder	1.42e-05	0.000101	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL2—autistic disorder	1.42e-05	0.000101	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—MAPK1—autistic disorder	1.42e-05	0.000101	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PRKCB—autistic disorder	1.42e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GRM5—autistic disorder	1.4e-05	9.97e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VIP—autistic disorder	1.4e-05	9.97e-05	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MAPK1—autistic disorder	1.38e-05	9.86e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GRM5—autistic disorder	1.38e-05	9.84e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VIP—autistic disorder	1.38e-05	9.84e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AVP—autistic disorder	1.37e-05	9.76e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APC—autistic disorder	1.36e-05	9.66e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CG—autistic disorder	1.36e-05	9.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—OXTR—autistic disorder	1.35e-05	9.65e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SERPINE1—autistic disorder	1.35e-05	9.65e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TSC2—autistic disorder	1.35e-05	9.64e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AVP—autistic disorder	1.35e-05	9.64e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PRKCB—autistic disorder	1.35e-05	9.61e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SCT—autistic disorder	1.34e-05	9.56e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGF—autistic disorder	1.34e-05	9.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—OXTR—autistic disorder	1.34e-05	9.53e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRB2—autistic disorder	1.32e-05	9.43e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SCT—autistic disorder	1.32e-05	9.43e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—LEP—autistic disorder	1.32e-05	9.43e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APOE—autistic disorder	1.32e-05	9.43e-05	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—autistic disorder	1.31e-05	9.34e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRB2—autistic disorder	1.31e-05	9.31e-05	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	1.3e-05	9.24e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—autistic disorder	1.29e-05	9.2e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APC—autistic disorder	1.29e-05	9.2e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CG—autistic disorder	1.29e-05	9.2e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MAPK1—autistic disorder	1.29e-05	9.17e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GABBR1—autistic disorder	1.28e-05	9.12e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADM—autistic disorder	1.28e-05	9.12e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGF—autistic disorder	1.28e-05	9.09e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GABBR1—autistic disorder	1.26e-05	9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADM—autistic disorder	1.26e-05	9e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EIF4E—autistic disorder	1.26e-05	8.96e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PRKCB—autistic disorder	1.25e-05	8.89e-05	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—HRAS—autistic disorder	1.25e-05	8.88e-05	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—HRAS—autistic disorder	1.25e-05	8.88e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE4B—autistic disorder	1.25e-05	8.88e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AVP—autistic disorder	1.24e-05	8.86e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF1—autistic disorder	1.24e-05	8.85e-05	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	1.24e-05	8.85e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EIF4E—autistic disorder	1.24e-05	8.84e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—MAPK1—autistic disorder	1.24e-05	8.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE4B—autistic disorder	1.23e-05	8.77e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—autistic disorder	1.23e-05	8.76e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AVP—autistic disorder	1.23e-05	8.75e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—OPRM1—autistic disorder	1.21e-05	8.6e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CG—autistic disorder	1.19e-05	8.51e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APC—autistic disorder	1.19e-05	8.51e-05	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—autistic disorder	1.19e-05	8.5e-05	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—autistic disorder	1.19e-05	8.5e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—OPRM1—autistic disorder	1.19e-05	8.49e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF1—autistic disorder	1.18e-05	8.42e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGF—autistic disorder	1.18e-05	8.41e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SERPINE1—autistic disorder	1.18e-05	8.4e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—MAPK1—autistic disorder	1.18e-05	8.38e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PLA2G4A—autistic disorder	1.17e-05	8.33e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PLA2G4A—autistic disorder	1.15e-05	8.23e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR2A—autistic disorder	1.14e-05	8.12e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HRAS—autistic disorder	1.14e-05	8.12e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—autistic disorder	1.14e-05	8.1e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR2A—autistic disorder	1.12e-05	8.02e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SERPINE1—autistic disorder	1.12e-05	8e-05	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HRAS—autistic disorder	1.11e-05	7.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GZMB—autistic disorder	1.1e-05	7.87e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—autistic disorder	1.1e-05	7.81e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF1—autistic disorder	1.09e-05	7.79e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—autistic disorder	1.09e-05	7.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GZMB—autistic disorder	1.09e-05	7.77e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—MAPK1—autistic disorder	1.09e-05	7.76e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—OXT—autistic disorder	1.07e-05	7.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR1B—autistic disorder	1.07e-05	7.64e-05	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—autistic disorder	1.06e-05	7.58e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—OXT—autistic disorder	1.06e-05	7.54e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR1B—autistic disorder	1.06e-05	7.54e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SERPINE1—autistic disorder	1.04e-05	7.4e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2A—autistic disorder	1.03e-05	7.38e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HRAS—autistic disorder	1.03e-05	7.36e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PTEN—autistic disorder	1.03e-05	7.35e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2A—autistic disorder	1.02e-05	7.28e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PRKCB—autistic disorder	9.99e-06	7.12e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSC1—autistic disorder	9.97e-06	7.1e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD1—autistic disorder	9.97e-06	7.1e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HRAS—autistic disorder	9.92e-06	7.07e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—autistic disorder	9.89e-06	7.05e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PRKCB—autistic disorder	9.86e-06	7.03e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD1—autistic disorder	9.84e-06	7.01e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSC1—autistic disorder	9.84e-06	7.01e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK2—autistic disorder	9.69e-06	6.91e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD3—autistic disorder	9.65e-06	6.88e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK2—autistic disorder	9.57e-06	6.82e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CG—autistic disorder	9.56e-06	6.81e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—autistic disorder	9.54e-06	6.8e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD3—autistic disorder	9.53e-06	6.79e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—autistic disorder	9.49e-06	6.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL5—autistic disorder	9.45e-06	6.73e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HRAS—autistic disorder	9.44e-06	6.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CG—autistic disorder	9.44e-06	6.73e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CALCA—autistic disorder	9.33e-06	6.65e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL5—autistic disorder	9.33e-06	6.65e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CALCA—autistic disorder	9.21e-06	6.57e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—autistic disorder	9.1e-06	6.49e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—autistic disorder	9.08e-06	6.47e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PRKCB—autistic disorder	9.07e-06	6.47e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—autistic disorder	9.04e-06	6.44e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—autistic disorder	8.98e-06	6.4e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTEN—autistic disorder	8.98e-06	6.4e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PRKCB—autistic disorder	8.96e-06	6.38e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HRAS—autistic disorder	8.74e-06	6.23e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CG—autistic disorder	8.68e-06	6.19e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CG—autistic disorder	8.57e-06	6.11e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTEN—autistic disorder	8.55e-06	6.09e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—autistic disorder	8.4e-06	5.99e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAPK1—autistic disorder	8.39e-06	5.98e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—autistic disorder	8.36e-06	5.96e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—autistic disorder	8.27e-06	5.89e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRL—autistic disorder	8.24e-06	5.87e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—autistic disorder	8.16e-06	5.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRL—autistic disorder	8.14e-06	5.8e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTEN—autistic disorder	7.91e-06	5.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB2—autistic disorder	7.82e-06	5.57e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB2—autistic disorder	7.72e-06	5.5e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AVP—autistic disorder	7.35e-06	5.24e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF2—autistic disorder	7.31e-06	5.21e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK1—autistic disorder	7.3e-06	5.2e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AVP—autistic disorder	7.25e-06	5.17e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF2—autistic disorder	7.22e-06	5.15e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK1—autistic disorder	6.95e-06	4.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLA2G4A—autistic disorder	6.91e-06	4.92e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLA2G4A—autistic disorder	6.82e-06	4.86e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HRAS—autistic disorder	6.73e-06	4.8e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—autistic disorder	6.73e-06	4.8e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MEF2C—autistic disorder	6.72e-06	4.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—autistic disorder	6.64e-06	4.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MEF2C—autistic disorder	6.63e-06	4.73e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ITGB3—autistic disorder	6.55e-06	4.67e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ITGB3—autistic disorder	6.46e-06	4.61e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—autistic disorder	6.44e-06	4.59e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK1—autistic disorder	6.43e-06	4.58e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2A—autistic disorder	6.11e-06	4.36e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—autistic disorder	6.11e-06	4.35e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2A—autistic disorder	6.04e-06	4.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—autistic disorder	6.03e-06	4.3e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HRAS—autistic disorder	5.86e-06	4.18e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSC2—autistic disorder	5.81e-06	4.14e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSC2—autistic disorder	5.73e-06	4.09e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOE—autistic disorder	5.68e-06	4.05e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—autistic disorder	5.68e-06	4.05e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOE—autistic disorder	5.61e-06	4e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—autistic disorder	5.61e-06	4e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—autistic disorder	5.61e-06	4e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HRAS—autistic disorder	5.58e-06	3.98e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCB—autistic disorder	5.36e-06	3.82e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—autistic disorder	5.34e-06	3.8e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCB—autistic disorder	5.29e-06	3.77e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HRAS—autistic disorder	5.16e-06	3.68e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APC—autistic disorder	5.13e-06	3.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	5.13e-06	3.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGF—autistic disorder	5.07e-06	3.61e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APC—autistic disorder	5.06e-06	3.61e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	5.06e-06	3.61e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGF—autistic disorder	5.01e-06	3.57e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—autistic disorder	4.94e-06	3.52e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—autistic disorder	4.88e-06	3.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—autistic disorder	4.82e-06	3.44e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1—autistic disorder	4.7e-06	3.35e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	4.67e-06	3.33e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1—autistic disorder	4.64e-06	3.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	4.61e-06	3.29e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	4.46e-06	3.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	4.4e-06	3.14e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HRAS—autistic disorder	3.75e-06	2.67e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HRAS—autistic disorder	3.7e-06	2.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—autistic disorder	3.61e-06	2.57e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—autistic disorder	3.59e-06	2.56e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—autistic disorder	3.56e-06	2.54e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—autistic disorder	3.55e-06	2.53e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTEN—autistic disorder	3.4e-06	2.42e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTEN—autistic disorder	3.35e-06	2.39e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK1—autistic disorder	2.76e-06	1.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK1—autistic disorder	2.73e-06	1.94e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HRAS—autistic disorder	2.22e-06	1.58e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HRAS—autistic disorder	2.19e-06	1.56e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—autistic disorder	2.12e-06	1.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—autistic disorder	2.09e-06	1.49e-05	CbGpPWpGaD
